Search Results - "LAURELL, Anna"
-
1
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Published in Journal of clinical oncology (10-08-2009)“…Temsirolimus, a specific inhibitor of the mammalian target of rapamycin kinase, has shown clinical activity in mantle cell lymphoma (MCL). We evaluated two…”
Get full text
Journal Article -
2
Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial
Published in The Lancet. Haematology (01-03-2018)“…Regimens based on ibrutinib alone and lenalidomide and rituximab in combination show high activity in patients with relapsed or refractory mantle cell…”
Get full text
Journal Article -
3
Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program
Published in Journal of clinical oncology (01-05-2009)“…To offer minimized risk-adapted adjuvant treatment on a nationwide basis for patients with clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer…”
Get full text
Journal Article -
4
Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group
Published in Journal of clinical oncology (20-02-2011)“…A binational, population-based treatment protocol was established to prospectively treat and follow patients with seminomatous testicular cancer. The aim was…”
Get full text
Journal Article -
5
Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma
Published in Haematologica (Roma) (01-11-2018)Get full text
Journal Article -
6
Dual Lewis Acid/Lewis Base Catalyzed Acylcyanation of Aldehydes: A Mechanistic Study
Published in Chemistry : a European journal (07-03-2016)“…A mechanistic investigation, which included a Hammett correlation analysis, evaluation of the effect of variation of catalyst composition, and low‐temperature…”
Get full text
Journal Article -
7
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
Published in Blood (25-02-2010)“…Mantle cell lymphoma (MCL) has a heterogeneous clinical course. The recently proposed Mantle Cell Lymphoma International Prognostic Index (MIPI) predicted the…”
Get full text
Journal Article -
8
Dissipative Cyclic Reaction Networks: Mechanistic Insights into a Minor Enantiomer Recycling Process
Published in ChemSystemsChem (01-03-2024)“…An analysis of an out‐of‐equilibrium cyclic reaction network which continuously converts a minor undesired product enantiomer to the desired major enantiomer…”
Get full text
Journal Article -
9
Recycling Powered by Release of Carbon Dioxide
Published in ChemCatChem (01-12-2014)“…In a cyclic process, fed with external chemical energy generated by the transformation of a compound with high chemical potential to carbon dioxide, the…”
Get full text
Journal Article -
10
Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
Published in Journal of clinical oncology (10-09-2009)“…Minimal residual disease (MRD) is predictive of clinical progression in mantle-cell lymphoma (MCL). According to the Nordic MCL-2 protocol we prospectively…”
Get full text
Journal Article -
11
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
Published in BMC cancer (06-06-2014)“…To determine whether changes in the metabolism of metastatic renal cell carcinoma (mRCC) assessed by F18-FDG-PET after 14 and 28 days of treatment with…”
Get full text
Journal Article -
12
Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma
Published in Journal for immunotherapy of cancer (20-06-2017)“…Accumulating pre-clinical data indicate that the efficient induction of antigen-specific cytotoxic CD8+ T cells characterizing viral infections is caused by…”
Get full text
Journal Article -
13
Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer Group
Published in Journal of clinical oncology (20-05-2011)“…From 1995 to 2003, 603 adult patients from Sweden and Norway with metastatic testicular nonseminomatous germ cell tumor (NSGCT) were included prospectively in…”
Get full text
Journal Article Magazine Article -
14
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
Published in European urology open science (Online) (01-06-2022)“…Intratumoral injection of ilixadencel, consisting of proinflammatory allogeneic dendritic cells, before nephrectomy, followed by sunitinib treatment after…”
Get full text
Journal Article -
15
Opposite Enantiomers from Minor Enantiomer Recycling and Dynamic Kinetic Resolution Using a Single Biocatalyst
Published in European Journal of Organic Chemistry (01-07-2011)“…A one‐pot recycling procedure comprising Lewis acid catalyzed enantioselective addition of acetyl cyanide to (E)‐2‐butenal to give the O‐acetylated cyanohydrin…”
Get full text
Book Review Journal Article -
16
Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer
Published in Acta oncologica (26-11-2015)“…Whole body (WB) magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI) has become increasingly utilized in cancer imaging, yet the…”
Get more information
Journal Article -
17
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
Published in British journal of haematology (01-11-2016)“…Summary In recent decades, the prognosis of Mantle Cell Lymphoma (MCL) has been significantly improved by intensified first‐line regimens containing…”
Get full text
Journal Article -
18
Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
Published in Blood (06-10-2016)“…For elderly patients with mantle cell lymphoma (MCL), there is no defined standard therapy. In this multicenter, open-label phase 1/2 trial, we evaluated the…”
Get full text
Journal Article -
19
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur
Published in British journal of haematology (2012)“…Mantle cell lymphoma (MCL) is a heterogenic non-Hodgkin lymphoma entity, with a median survival of about 5 years. In 2008 we reported the early based on the…”
Get full text
Journal Article -
20
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study
Published in British journal of haematology (01-07-2014)“…Summary Mantle cell lymphoma (MCL) is an aggressive B cell lymphoma, where survival has been remarkably improved by use of protocols including high dose…”
Get full text
Journal Article